Haemonetics
297 hedge funds and large institutions have $4.37B invested in Haemonetics in 2024 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 104 increasing their positions, 115 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more capital invested
Capital invested by funds: $4.36B → $4.37B (+$4.53M)
10% less repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 115
Holders
297
Holding in Top 10
2
Calls
$14.6M
Puts
$5.04M
Top Buyers
| 1 | +$85.6M | |
| 2 | +$38.7M | |
| 3 | +$25.6M | |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$24.5M |
| 5 |
Neuberger Berman Group
New York
|
+$21.9M |
Top Sellers
| 1 | -$118M | |
| 2 | -$52.6M | |
| 3 | -$48.4M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$25.6M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$22.7M |